While the major uses for GLP-1s include those with type 2 diabetes and obesity, in March of 2024, the FDA also approved them for heart diseases
Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice
The science behind user experiences Moving beyond individual reviews to examine what the scientific literature tells us about why users report what they report
RELATED CONTENT: M&M 229: Linoleic Acid, Seed Oils, mTOR & Breast Cancer | Nikos Koundouros & John Blenis KNOW YOURSELF: Visit the SUPPORT PAGE if you find value in this content
A licensed provider will review your health history and, if appropriate, prescribe compounded GLP-1 medication the same active ingredients studied in published clinical trials with dose escalation and ongoing oversight built around your goals and your biology
GLP-1 may also inhibit ANG II action at post-receptor level